With 4.08 million shares changed hands, the volume of the stock remained heavier than its average volume of 3.11 million shares. The 52-week range on BBIO shows that it touched its highest point at $39.54 and its lowest point at $21.62 during that stretch. It currently has a 1-year price target of $59.59. Beta for the stock currently stands at 1.18.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BBIO was up-trending over the past week, with a rise of 1.43%, but this was up by 17.76% over a month. Three-month performance surged to 12.01% while six-month performance rose 57.80%. The stock gained 33.17% in the past year, while it has gained 34.62% so far this year. A look at the trailing 12-month EPS for BBIO yields -3.53 with Next year EPS estimates of -2.00. For the next quarter, that number is -0.79. This implies an EPS growth rate of -8.28% for this year and 35.99% for next year.
Float and Shares Shorts:
At present, 189.83 million BBIO shares are outstanding with a float of 155.25 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for BBIO since 9 analysts follow the stock currently. There are 9 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$2.30756 being high and -$2.69052 being low. For BBIO, this leads to a yearly average estimate of -$2.51377.
